Latest Post

March 10, 2021

Biosimilars Market Survey Brings Insight to Most Important Containment and Support Service Needs

Biosimilar development and approvals have been accelerated over the last several years. The rapid uptake in this category is due in large part to clarity on regulatory pathways that demonstrate interchangeability with the reference product and key patent expiry over the next decade. By 2025 injectable biosimilars are projected to comprise almost 50% of the accessible biologics market<sup>1</sup>. West recently conducted a survey of biosimilar companies to better understand their top needs for packaging and support services during drug development.
Abigail Hisler

Abbey Hisler

Director, Strategic Marketing, Biologics

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    By Your Side for Expertise

    March 18, 2020

    Understanding Industry Challenges

    Janina Lehmann

    Janina Lehmann, Ph.D.

    Sr. Director, Technical Customer Support

    By Your Side for Quality

    August 28, 2019

    By Your Side for Optimal Patient Outcomes – A Quality Perspective

    Andy Polywacz

    Andy Polywacz

    Vice President, Quality & Regulatory Affairs

    West elastomers

    September 19, 2017

    Product Recommendations – Selecting the Right Pharmaceutical Packaging Components

    Heike Kofler

    Heike Kofler, Ph.D.

    Manager, Technical Customer Support Europe

    Lab Viewing corridor

    May 09, 2017

    At Your Service – West Technical Customer Support

    Heike Kofler

    Heike Kofler, Ph.D.

    Manager, TCS, Europe

    Load more